11:01 AM EST - WELL Health Technologies Corp. : Announced its interim consolidated financial results for the quarter ended June 30, 2024. WELL achieved record quarterly revenues of $243.1 million in Q2-2024, an increase of 42% as compared to Q2-2023 driven by acquisitions and overall organic growth of 21%. WELL achieved record Adjusted EBITDA of $30.9 million in Q2-2024, an increase of 11% as compared to Q2-2023.
WELL Health Technologies Corp.
shares T.WELL are trading down $0.20 at $4.44.
